Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry

American Heart Journal

Volumn 173, Issue , 2016, Pages 172-178

  Devore, Adam D ^a,b   Mi, Xiaojuan ^a   Mentz, Robert J ^a,b   Fonarow, Gregg C ^c   Van Dyke, Melissa K ^d   Maya, Juan F ^d   Hardy, N Chantelle ^a   Hammill, Bradley G ^a   Hernandez, Adrian F ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IVABRADINE; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; TARTARIC ACID;

ACUTE HEART FAILURE; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DISEASE REGISTRY; DRUG USE; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT; UNITED STATES; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECTS; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REGISTER; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84960262299     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.10.026     Document Type: Article

References (17)

1. K. Swedberg, M. Komajda, M. Böhm, and et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
2. K. Swedberg, M. Komajda, M. Bohm, and et al. Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT) Eur J Heart Fail 12 2010 75 81
3. G.C. Fonarow, W.T. Abraham, N.M. Albert, and et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF): rationale and design Am Heart J 148 2004 43 51
4. C.W. Yancy, M. Jessup, B. Bozkurt, and et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 128 2013 e240 e327
5. W.B. Kannel, C. Kannel, R.S. Paffenbarger Jr., and et al. Heart rate and cardiovascular mortality: the Framingham Study Am Heart J 113 1987 1489 1494
6. K. Fox, J.S. Borer, A.J. Camm, and et al. Resting heart rate in cardiovascular disease J Am Coll Cardiol 50 2007 823 830
7. A.M. Pittaras, C. Faselis, M. Doumas, and et al. Heart rate at rest, exercise capacity, and mortality risk in veterans Am J Cardiol 112 2013 1605 1609
8. D. Castagno, H. Skali, M. Takeuchi, and et al. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program J Am Coll Cardiol 59 2012 1785 1795
9. C.M. O'Connor, W.T. Abraham, N.M. Albert, and et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) Am Heart J 156 2008 662 673
10. M.V. Habal, P.P. Liu, P.C. Austin, and et al. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure Circ Heart Fail 7 2014 12 20
11. W.K. Laskey, I. Alomari, M. Cox, and et al. Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization J Am Heart Assoc 4 4 2015 10.1161/JAHA.114.001626
12. S.J. Greene, M. Vaduganathan, J.E. Wilcox, and et al. The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial JACC Heart Fail 1 2013 488 496
13. M. Metra Tachycardia after a heart failure hospitalization: another piece of the puzzle? JACC Heart Fail 1 2013 497 499
14. J. Butler, P.G. Arbogast, J. Daugherty, and et al. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge J Am Coll Cardiol 43 2004 2036 2043
15. L.H. Curtis, X. Mi, L.G. Qualls, and et al. Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure Am Heart J 165 2013 979 986 e1
16. Z.J. Eapen, X. Mi, L.G. Qualls, and et al. Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation J Card Fail 20 2014 23 30
17. W.A. Gattis, C.M. O'Connor, D.S. Gallup, and et al. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial J Am Coll Cardiol 43 2004 1534 1541